Serum vitamin D levels in women with polycystic ovary syndrome
DOI:
https://doi.org/10.33448/rsd-v11i1.24971Keywords:
Polycystic Ovary Syndrome; Vitamin D; Obesity.Abstract
The aim of this study was to analyze the serum levels of vitamin D in patients with Polycystic Ovary Syndrome, comparing them with those of healthy women, both with different Body Mass Indexes. This is a cross-sectional study, carried out at the Endocrine Gynecology and Human Reproduction outpatient clinic at the Getúlio Vargas Hospital (HGV) and at the University Hospital of the Federal University of Piauí (HU-UFPI), from December 2016 to December 2017. The sample consisted of 151 women, divided into four groups (G1 = normal weight PCOS group (n = 35); G2 = overweight/obesity PCOS group (n = 44); G3 = normal weight control (n = 32); and, G4=overweight/obesity control (n = 40). Data collection occurred through a structured form by the researchers, which was guided by a standard operating procedure, containing sociodemographic and clinical data. Women in the PCOS group ( normal weight and overweight/obese) had lower vitamin D levels than control women (non-obese and obese), noting that those without PCOS with normal weight had higher vitamin D levels than in all other groups, which allows to state that there was a relationship of between vitamin D levels and the presence of PCOS (p<0.02). Most women with PCOS have lower serum vitamin D levels, both those of normal weight and those with obesity and overweight compared to healthy women in similar conditions of weight changes and this difference is statistically significant.
References
Abeso. Diretrizes Brasileiras de Obesidade. 2016. 4ed. São Paulo.
Aloia, J. F., Dhaliwal, R., Shieh, A., Mikhail, M., Fazzari, M., Ragolia, L., & Abrams, S. A. (2014). Vitamin D supplementation increases calcium absorption without a threshold effect. The American journal of clinical nutrition, 99(3), 624-631.
Al-Daghri, N. M., Alkharfy, K. M., Al-Saleh, Y., Al-Attas, O. S., Alokail, M. S., Al-Othman, A., ... & Chrousos, G. P. (2012). Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism, 61(5), 661-666.
Amal, S., Shalaby, S. M., Aly, N. M., Rashad, N. M., & Abdelaziz, A. M. (2013). Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Molecular biology reports, 40(11), 6063-6073.
Arantes, H. P., Kulak, C. A. M., Fernandes, C. E., Zerbini, C., Bandeira, F., Barbosa, I. C., ... & Lazaretti-Castro, M. (2013). Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial. Osteoporosis International, 24(10), 2707-2712.
Asemi, Z., Foroozanfard, F., Hashemi, T., Bahmani, F., Jamilian, M., & Esmaillzadeh, A. (2015). Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clinical nutrition, 34(4), 586-592.
Bart, C. J. M. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and sterility, 97(1), 28-38.
Batista, L. R., da Silva, C. A. B., Schneider, I. J. C., & Nunes, R. D. (2013). Fatores de risco à resistência insulínica em mulheres com síndrome dos ovários policísticos. ACM arq. catarin. med, 33-38.
Ben‐Noun, L., Sohar, E., & Laor, A. (2001). Neck circumference as a simple screening measure for identifying overweight and obese patients. Obesity research, 9(8), 470-477.
Blomberg Jensen, M., Nielsen, J. E., Jørgensen, A., Rajpert-De Meyts, E., Kristensen, D. M., Jørgensen, N., ... & Leffers, H. (2010). Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Human reproduction, 25(5), 1303-1311.
Brasil. Conselho Nacional de Saúde. Resolução nº 466, de 12 de dezembro de 2012. Diretrizes e Normas Regulamentadoras de Pesquisas Envolvendo Seres Humanos. Diário Oficial [da] União, Brasília, DF, n. 12, 13 de junho de 2013. Seção 71, p. 59.
Brum, D. G., Comini-Frota, E. R., Vasconcelos, C. C. F., & Dias-Tosta, E. (2014). Suplementação e uso terapêutico de vitamina D nos pacientes com esclerose múltipla: Consenso do Departamento Científico de Neuroimunologia da Academia Brasileira de Neurologia. Arquivos de Neuro-Psiquiatria, 72, 152-156.
Carmina, E. cardiovascular risk factors and events in polycystic ovary syndrome. Climacteric. 2009, v. 12, p. 22-5.
Carvalho, C. A. D., Fonseca, P. C. D. A., Barbosa, J. B., Machado, S. P., Santos, A. M. D., & Silva, A. A. M. D. (2015). Associação entre fatores de risco cardiovascular e indicadores antropométricos de obesidade em universitários de São Luís, Maranhão, Brasil. Ciência & Saúde Coletiva, 20, 479-490.
Cascella, T., Palomba, S., De Sio, I., Manguso, F., Giallauria, F., De Simone, B., ... & Orio, F. (2008). Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Human Reproduction, 23(1), 153-159.
Castro, L. C. G. D. (2011). O sistema endocrinológico vitamina D. Arquivos Brasileiros de Endocrinologia & Metabologia, 55, 566-575.
Cerqueira, J. M. C., Costa, L. O. B. F., Nogueira, A. D. A. V., Silva, D. C. C. D., Torres, D. D. O. C., & Santos, A. C. O. D. (2010). Homocisteinemia em mulheres com síndrome dos ovários policísticos. Revista Brasileira de Ginecologia e Obstetrícia, 32, 126-132.
Escobar, M. H. F. (2017). The role of androgen excess in metabolic dysfunction in women. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity, 597-608.
Speroff, L. Fritz, M. A. (2015). Endocrinologia Ginecológica Clínica e Infertilidad. Revinter, 8ª ed.
Evans, D. (2007). Overview of methods. In: WEBB, C.; ROE, B.; editors. Reviewing reserach evidence for nursing practice: systematic reviews. Oxford: Blackwell Publishing, p. 149-156.
Fang, F., Ni, K., Cai, Y., Shang, J., Zhang, X., & Xiong, C. (2017). Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary therapies in clinical practice, 26, 53-60.
Faria, F. R., Gusmão, L. S., de Faria, E. R., Gonçalves, V. S. S., Cecon, R. S., Franceschini, S. D. C. C., & Priore, S. E. (2013). Síndrome do ovário policístico e fatores relacionados em adolescentes de 15 a 18 anos. Revista da Associação Médica Brasileira, 59(4), 341-346.
Faraji, R., Sharami, S. H., Zahiri, Z., Asgharni, M., Kazemnejad, E., & Sadeghi, S. (2014). Evaluation of relation between anthropometric indices and vitamin D concentrations in women with polycystic ovarian syndrome. Journal of family & reproductive health, 8(3), 123.
Fauser, B. C., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., ... & Barnhart, K. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and sterility, 97(1), 28-38.
Fiel, A. (2009). Descobrindo a estatística usando o SPSS [recurso eletrônico]. Porto Alegre: Artmed. 2ª ed.
Flores, C. B., Flores, L., & Comim, F. V. (2013). Hirsutismo: avaliação e princípios do tratamento. Revista da AMRIGS, 57(3), 232-9.
Gallea, H. et al. (2014). A insulina e o peso corporal, mas não parecem hiperandrogenismo envolvido no soro sazonal 25-OH-vitamina D3 níveis em indivíduos afectados por SOP. Gynecol Endocrinol., v. 30, n. 3, p. 739-45.
Galvão, C. M., Mendes, K. D. S., & Silveira, R. C. C. P. (2010). Revisão integrativa: método de revisão para sintetizar as evidências disponíveis na literatura. Brevidelli MM, Sertório SCM. Trabalho de conclusão de curso: guia prático para docentes e alunos da área da saúde. São Paulo: Iátrica, 105-26.
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology, 7(4), 219-231.
Gray, J.; Grove, S.; Sutherland, S. The Practice of Nursing Research: appraisal, synthesis, and generation of evidence. 8th. Rio de Janeiro: Elsevier, 2016.
Groot, P. C., Dekkers, O. M., Romijn, J. A., Dieben, S. W., & Helmerhorst, F. M. (2011). PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human reproduction update, 17(4), 495-500.
Hagenau, T., Vest, R., Gissel, T. N., Poulsen, C. S., Erlandsen, M., Mosekilde, L., & Vestergaard, P. (2009). Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporosis international, 20(1), 133-140.
He, C., Lin, Z., Robb, S. W., & Ezeamama, A. E. (2015). Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients, 7(6), 4555-4577.
Holick, M. F., & Chen, T. C. (2008). Vitamin D deficiency: a worldwide problem with health consequences. The American journal of clinical nutrition, 87(4), 1080S-1086S.
F Holick, M. (2011). Vitamin D: evolutionary, physiological and health perspectives. Current drug targets, 12(1), 4-18.
Huber, M. M., Carey, D. G. P., & Norman, R. J. (1999). Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. The Journal of Clinical Endocrinology & Metabolism, 84(4), 1470-1474.
Irani, M., & Merhi, Z. (2014). Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertility and sterility, 102(2), 460-468.
Jalilian, N., Haghnazari, L., & Rasolinia, S. (2016). Leptin and body mass index in polycystic ovary syndrome. Indian journal of endocrinology and metabolism, 20(3), 324.
Joham, A. E., Teede, H. J., Cassar, S., Stepto, N. K., Strauss, B. J., Harrison, C. L., ... & de Courten, B. (2016). Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance. Molecular nutrition & food research, 60(1), 110-118.
Kayaniyil, S., Vieth, R., Harris, S. B., Retnakaran, R., Knight, J. A., Gerstein, H. C., ... & Hanley, A. J. (2011). Association of 25 (OH) D and PTH with metabolic syndrome and its traditional and nontraditional components. The Journal of clinical endocrinology & metabolism, 96(1), 168-175.
Kim, J. J. et al. (2014). Vitamin D deficiency in women with polycystic ovary syndrome. Clin. Ex. Reprod. Med., v. 41, n. 2, p. 80-85.
Li, H. W. R. et al. (2015). A deficiência de vitamina D é comum e associada a fatores de risco metabólicos em pacientes com síndrome do ovário policístico. Metabolismo. v. 60, n. 10, p. 1475-481.
Lichtenstein, A., Ferreira-Júnior, M., Sales, M. M., Aguiar, F. B. D., Fonseca, L. A. M., Sumita, N. M., & Duarte, A. J. (2013). Vitamina D: ações extraósseas e uso racional. Revista da Associação Médica Brasileira, 59, 495-506.
Lima, C. R. O. C., dos Santos, L. A., Lemaire, D. C., Rios, D. L., da Conceição, G. C., Brandão, N. A., & Araújo, E. M. Q. (2017). Associação entre níveis séricos de vitamina D e componentes da síndrome metabólica em pacientes atendidos no centro de estudos e atendimento dietoterápico da Universidade do Estado da Bahia. Revista de Ciências Médicas e Biológicas, 16(3), 367-373.
Lin, M. W., & Wu, M. H. (2015). The role of vitamin D in polycystic ovary syndrome. The Indian journal of medical research, 142(3), 238.
Malachias, M. V. B., Souza, W. K. S. B., Plavnik, F. L., Rodrigues, C. I. S., Brandão, A. A., & Neves, M. F. T. (2016). IV Diretriz Brasileira de Hipertensão Arterial. Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia, 107(3), 7-12.
Malta, D. C., Andrade, S. C., Claro, R. M., Bernal, R. T. I., & Monteiro, C. A. (2014). Evolução anual da prevalência de excesso de peso e obesidade em adultos nas capitais dos 26 estados brasileiros e no Distrito Federal entre 2006 e 2012. Revista Brasileira de Epidemiologia, 17, 267-276.
Maeda, S. S., Borba, V. Z., Camargo, M. B. R., Silva, D. M. W., Borges, J. L. C., Bandeira, F., & Lazaretti-Castro, M. (2014). Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arquivos Brasileiros de Endocrinologia & Metabologia, 58, 411-433.
Malachias, M. V. B. et al. (2016). 7ª Diretriz Brasileira de Hipertensão Arterial. Sociedade Brasileira de Cardiologia. Arq Bras Cardiol., v. 107, n. 3, Supl 3, p. 1-83.
Meireles, G. R. M. et al. (2017). Vitamin D and Polycystic Ovary Syndrome: Integrative Review. International Archives of Medicine Section: Obstetrics & Ginecology, v. 10, n. 132, p. 1-7.
Mishra, S., Das, A. K., & Das, S. (2016). Hypovitaminosis D and associated cardiometabolic risk in women with PCOS. Journal of clinical and diagnostic research: JCDR, 10(5), BC01.
Mithal, A. et al. (2009). Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int., v. 20, n. 11, p. 1807-820.
Norman, A. W. (2008). From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. The American journal of clinical nutrition, 88(2), 491S-499S.
Panidis, D. et al.(2009). As concentrações séricas de hormônio paratiroideiro são aumentadas em mulheres com síndrome do ovário policístico. Clin Chem. v. 51, n. 9, p. 1691-97.
Pocock, S. J. (1989). Basic principles of statistical analysis: Clinical trials: a practical approach. Chinchester: John Wiley & Sons.
Premaor, M. O., & Furlanetto, T. W. (2006). Hipovitaminose D em adultos: entendendo melhor a apresentação de uma velha doença. Arquivos Brasileiros de Endocrinologia & Metabologia, 50, 25-37.
Raja-Khan, N., Shah, J., Stetter, C. M., Lott, M. E., Kunselman, A. R., Dodson, W. C., & Legro, R. S. (2014). High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertility and sterility, 101(6), 1740-1746.
Randeva, H. S., Lewandowski, K. C., Drzewoski, J., Brooke-Wavell, K., O’Callaghan, C., Czupryniak, L., ... & Prelevic, G. M. (2002). Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 87(10), 4496-4501.
Rodríguez, S. M. et al. (2007). The contribution of diet and sun exposure to the nutritional status of vitamin D in elderly Spanish women: the five countries study (OPTIFORD Project). Nutr. Hosp. v. 23, n. 6, p. 567-76.
Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human reproduction, 19(1), 41-47.
Santos Junior, E. et al. (2018). Epidemiologia da deficiência de vitamina D. Revista Científica do ITPAC, Araguaína, v.4, n.3, p. 22-32.
Santos, L. F.; Araújo, E. M. Q.; Melo, J. B. (2013). Avaliação da prevalência de hipovitaminose D em pacientes portadores de síndrome metabólica do centro de estudos e atendimento dietoterápico de Salvador, Bahia. Rev. Bras. Medic., Salvador, v.70, n. 7.
SANTOS, A. (2011). Papel da vitamina D no risco cardiovascular. Rev. Facto de Ris, Porto, v. 20, n. 9, p. 18-23.
Saraiva, G. L., Cendoroglo, M. S., Ramos, L. R., Araújo, L. M. Q., Vieira, J. G. H., Maeda, S. S., ... & Lazaretti-Castro, M. (2007). Prevalência da deficiência, insuficiência de vitamina D e hiperparatiroidismo secundário em idosos institucionalizados e moradores na comunidade da cidade de São Paulo, Brasil. Arquivos Brasileiros de Endocrinologia & Metabologia, 51, 437-442.
Scott, D., Joham, A., Teede, H., Gibson-Helm, M., Harrison, C., Cassar, S., ... & De Courten, B. (2016). Associations of vitamin D with inter-and intra-muscular adipose tissue and insulin resistance in women with and without polycystic ovary syndrome. Nutrients, 8(12), 774.
Senhor, J. et al. (2006). Wilkin the central issue? visceral fat mass is a good marker of insulin resistance and metabolic disorders in women with polycystic ovary syndrome. BJOG, v. 113, p. 1203-9.
Silva Filho, A. L; Laranjeira, C. L. S. (2017). Manual SOGIMIG de Ginecologia e Obstetrícia. 6ed. Rio de Janeiro: Medbook.
Spritzer, P. M., & Wiltgen, D. (2007). Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS). Arquivos brasileiros de endocrinologia e metabologia, 51(1), 146-147.
SOCIEDADE BRASILEIRA DE DIABETES. (2018). Diretrizes da Sociedade Brasileira de Diabetes. 6. ed. São Paulo:Clannad.
SOCIEDADE BRASILEIRA DE CARDIOLOGIA. (2016). VII Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. São Paulo, v. 107, supl. 3, p. 7-13.
Sousa, R. M. L. D., Chein, M. B. D. C., Silva, D. S. M. D., Dutra, M. B., Navarro, P. A. D. A. S., Figueiredo Neto, J. A. D., & Brito, L. M. O. (2013). Perfil metabólico em mulheres de diferentes índices de massa corporal com síndrome dos ovários policísticos. Revista Brasileira de Ginecologia e Obstetrícia, 35, 413-420.
Stabe, C., Vasques, A. C. J., Lima, M. M. O., Tambascia, M. A., Pareja, J. C., Yamanaka, A., & Geloneze, B. (2013). Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clinical endocrinology, 78(6), 874-881.
Wehr, E., Pilz, S., Schweighofer, N., Giuliani, A., Kopera, D., Pieber, T. R., & Obermayer-Pietsch, B. (2009). Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. European Journal of Endocrinology, 161(4), 575-582.
Thacher, T. D.; Clarke, B. L. (2011). Vitamina Dinsuficiency. Mayo Clinic Procedings, v. 86, p. 50-60.
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology, 77(3), 343-350.
Wijeyaratne, C. N., Seneviratne, R. D. A., Dahanayake, S., Kumarapeli, V., Palipane, E., Kuruppu, N., ... & Balen, A. H. (2011). Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Human Reproduction, 26(1), 202-213.
Yau, T. T., Ng, N. Y., Cheung, L. P., & Ma, R. C. (2017). Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences. Hong Kong Med J, 23(6), 622-34.
Yildizhan, R., Kurdoglu, M., Adali, E., Kolusari, A., Yildizhan, B., Sahin, H. G., & Kamaci, M. (2009). Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of gynecology and obstetrics, 280(4), 559-563.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Caroliny Gonçalves Rodrigues Meireles; Ione Maria Ribeiro Soares Lopes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
